Skip to main content
About Us
Company Profile
Philosophy
Milestones
Organization
Leadership Team
R&D Team
Products & Technology
Diabetes Care
CDMO & Transfer
Technology
News
Investor Relations
Board of Directors
Material Information
Governance Documents
Financial Information
Shareholders
Shareholder Services
Investor Conference
Committees
Sustainability Reports
ESG
Environment
Social
Governance
Stakeholder Engagement
Contact
中文
EN
Material Information
Material information announcements filed by the Company
Home
/
Investor Relations
/
Material Information
All
2026
07/08/2026
fw
Paragraph 4
05/12/2026
Board of Directors approved the 2025 annual financial statements
Paragraph 11
03/20/2026
Obtained U.S. FDA 510(k) clearance for a medical device
Paragraph 53
01/08/2026
Announcement of self-settled revenue for December 2025
Paragraph 2